SOD1 and amyotrophic lateral sclerosis: The overexpression of GPX4 in ALS mouse models exhibits reduced systemic cytotoxicity of SOD1, late delayed disease-onset, improved motor function, and longer survival, which are associated with faster recovery from spinal motor neuron injury and repressed lipid peroxidation (Chen X. et al., 2021).